Find Research Projects

Search results

• Understanding COVID-19 Disease and Developing Countermeasures

  Weaver, S.

  Sealy & Smith Foundation

  4/15/20 → 4/14/22

  Project: Other project

• Testing polymer surfaces for antiviral activity against SARS-CoV-2

  Endsley, M.

  Kraton Polymers LLC

  4/15/20 → 6/1/21

  Project: Other project

• Understanding COVID-19 Disease and Developing Countermeasures

  Weaver, S.

  4/15/20 → 4/14/22

  Project: Other project

• Understanding COVID-19 Disease and Developing Countermeasures

  Weaver, S.

  Sealy & Smith Foundation

  4/15/20 → 4/14/22

  Project: Other project

• Understanding COVID-19 Disease and Developing Countermeasures

  Weaver, S.

  Sealy & Smith Foundation

  4/15/20 → 4/14/22

  Project: Other project

• Understanding COVID-19 Disease and Developing Countermeasures

  Weaver, S.

  Sealy & Smith Foundation

  4/15/20 → 4/14/22

  Project: Other project

• Understanding COVID-19 Disease and Developing Countermeasures

  Weaver, S.

  Sealy & Smith Foundation

  4/15/20 → 4/14/22

  Project: Other project

• Understanding COVID-19 Disease and Developing Countermeasures

  Weaver, S.

  4/15/20 → 4/14/22

  Project: Other project

• Modeling age-dependent susceptibility to SARS-CoV-2 infection in 3D human lung organoids

  Aguilar, P.

  4/15/20 → 12/31/20

  Project: Other project

• Understanding COVID-19 Disease and Developing Countermeasures

  Weaver, S.

  Sealy & Smith Foundation

  4/15/20 → 4/14/22

  Project: Other project

• Understanding COVID-19 Disease and Developing Countermeasures

  Weaver, S.

  Sealy & Smith Foundation

  4/15/20 → 4/14/22

  Project: Other project

• Properties of Niclosamide against SARS-COV-2

  Shi, P.

  4/15/20 → 6/15/20

  Project: Other project

• Understanding COVID-19 Disease and Developing Countermeasures

  Weaver, S.

  Sealy & Smith Foundation

  4/15/20 → 4/14/22

  Project: Other project

• Understanding COVID-19 Disease and Developing Countermeasures

  Weaver, S.

  Sealy & Smith Foundation

  4/15/20 → 4/14/22

  Project: Other project

• Understanding COVID-19 Disease and Developing Countermeasures

  Weaver, S.

  4/15/20 → 4/14/22

  Project: Other project

• Modeling age-dependent susceptibility to SARS-CoV-2 infection in 3D human lung organoids

  Aguilar, P.

  Emergent Ventures

  4/15/20 → 12/31/20

  Project: Other project

• Understanding COVID-19 Disease and Developing Countermeasures

  Weaver, S.

  Sealy & Smith Foundation

  4/15/20 → 4/14/22

  Project: Other project

• Understanding COVID-19 Disease and Developing Countermeasures

  Weaver, S.

  4/15/20 → 4/14/22

  Project: Other project

• Continuation of the nuMoM2b Heart Health Study

  Saade, G.

  4/15/20 → 1/31/27

  Project: Other project

• Continuation of the nuMoM2b Heart Health Study

  Saade, G.

  RTI International

  4/15/20 → 1/31/27

  Project: Other project

• Understanding COVID-19 Disease and Developing Countermeasures

  Weaver, S.

  Sealy & Smith Foundation

  4/15/20 → 4/14/22

  Project: Other project

• Understanding COVID-19 Disease and Developing Countermeasures

  Weaver, S.

  Sealy & Smith Foundation

  4/15/20 → 4/14/22

  Project: Other project

• Understanding COVID-19 Disease and Developing Countermeasures

  Weaver, S.

  Sealy & Smith Foundation

  4/15/20 → 4/14/22

  Project: Other project

• Understanding COVID-19 Disease and Developing Countermeasures

  Weaver, S.

  4/15/20 → 4/14/22

  Project: Other project

• Understanding COVID-19 Disease and Developing Countermeasures

  Weaver, S.

  4/15/20 → 4/14/22

  Project: Other project

• Properties of Niclosamide against SARS-COV-2

  Shi, P.

  Ana Therapeutics Inc

  4/15/20 → 6/15/20

  Project: Other project

• Understanding COVID-19 Disease and Developing Countermeasures

  Weaver, S.

  Sealy & Smith Foundation

  4/15/20 → 4/14/22

  Project: Other project

• Understanding COVID-19 Disease and Developing Countermeasures

  Weaver, S.

  Sealy & Smith Foundation

  4/15/20 → 4/14/22

  Project: Other project

• Understanding COVID-19 Disease and Developing Countermeasures

  Weaver, S.

  4/15/20 → 4/14/22

  Project: Other project

• Understanding COVID-19 Disease and Developing Countermeasures

  Weaver, S.

  Sealy & Smith Foundation

  4/15/20 → 4/14/22

  Project: Other project

• Understanding COVID-19 Disease and Developing Countermeasures

  Weaver, S.

  Sealy & Smith Foundation

  4/15/20 → 4/14/22

  Project: Other project

• Understanding COVID-19 Disease and Developing Countermeasures

  Weaver, S.

  Sealy & Smith Foundation

  4/15/20 → 4/14/22

  Project: Other project

• Understanding COVID-19 Disease and Developing Countermeasures

  Weaver, S.

  4/15/20 → 4/14/22

  Project: Other project

• Understanding COVID-19 Disease and Developing Countermeasures

  Weaver, S.

  Sealy & Smith Foundation

  4/15/20 → 4/14/22

  Project: Other project

• Understanding COVID-19 Disease and Developing Countermeasures

  Weaver, S.

  4/15/20 → 4/14/22

  Project: Other project

• Understanding COVID-19 Disease and Developing Countermeasures

  Weaver, S.

  Sealy & Smith Foundation

  4/15/20 → 4/14/22

  Project: Other project

• Testing polymer surfaces for antiviral activity against SARS-CoV-2

  Endsley, M.

  4/15/20 → 6/1/21

  Project: Other project

• Understanding COVID-19 Disease and Developing Countermeasures

  Weaver, S.

  4/15/20 → 4/14/22

  Project: Other project

• Fee Revenue: CON29090 - Authentic Live Virus Assay (up to 50 samples tested); Lilly #1

  Urban, R.

  4/16/20 → 8/31/21

  Project: Other project

• Authentic Live Virus Assay (up to 50 samples tested); Lilly #1

  Geisbert, T.

  Eli Lilly & Company

  4/16/20 → 11/5/21

  Project: Other project

• Authentic Live Virus Assay (up to 50 samples tested); Lilly #1

  Geisbert, T.

  Eli Lilly & Company

  4/16/20 → 9/1/21

  Project: Other project

• Authentic Live Virus Assay (up to 50 samples tested); Lilly #1

  Geisbert, T.

  4/16/20 → 11/5/21

  Project: Other project

• Authentic Live Virus Assay (up to 50 samples tested); Lilly #1

  Geisbert, T.

  Eli Lilly & Company

  4/16/20 → 9/1/21

  Project: Other project

• Authentic Live Virus Assay (up to 50 samples tested); Lilly #1

  Geisbert, T.

  4/16/20 → 11/5/21

  Project: Other project

• Authentic Live Virus Assay (up to 50 samples tested); Lilly #1

  Geisbert, T.

  Eli Lilly & Company

  4/16/20 → 9/1/21

  Project: Other project

• Authentic Live Virus Assay (up to 50 samples tested); Lilly #1

  Geisbert, T.

  Eli Lilly & Company

  4/16/20 → 9/1/21

  Project: Other project

• Authentic Live Virus Assay (up to 50 samples tested); Lilly #1

  Geisbert, T.

  Eli Lilly & Company

  4/16/20 → 9/1/21

  Project: Other project

• Authentic Live Virus Assay (up to 50 samples tested); Lilly #1

  Geisbert, T.

  4/16/20 → 11/5/21

  Project: Other project

• Fee Revenue: CON29090 - Authentic Live Virus Assay (up to 50 samples tested); Lilly #1

  Urban, R.

  4/16/20 → 8/31/21

  Project: Other project

• Authentic Live Virus Assay (up to 50 samples tested); Lilly #1

  Geisbert, T.

  4/16/20 → 11/5/21

  Project: Other project